We are pleased to announce that Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has entered into a definitive share exchange agreement with fitters Sdn. Bhd., a wholly owned subsidiary of FITTERS Diversified Berhad  (9318.KL; “FITTERS”) for a proposed business combination. The transaction, if completed, will result in fitters Sdn. Bhd. becoming a wholly owned subsidiary […]

D. Boral and ARC Group Further Strengthen SPAC Leadership and Global Presence with a Series of SPAC IPOs Beginning in 2025 NEW YORK – May 5, 2025 – D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, and ARC Group, a leading global investment bank and management consultancy firm, are […]

We are pleased to announce that Sayward Capital Corp. (TSXV: SAWC.P) (“Sayward” or the “Company”) and Technosteel Construction (L.L.C.) (“Technosteel”) have executed a definitive share exchange agreement (the “Definitive Agreement”) for a proposed business combination. This marks a significant milestone in the transaction process first initiated through the non-binding letter of intent dated June 13, […]

We are pleased to announce that BeLive Holdings, a Singapore-based provider of live commerce and shoppable short video solutions, has successfully priced its initial public offering on the Nasdaq Capital Market under the ticker symbol “BLIV.” . The offering consisted of 2,450,000 ordinary shares at a price of US$4.00 per share, resulting in gross proceeds […]

ARC Group is pleased to announce that Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, CYCCP), a clinical-stage biopharmaceutical company, has successfully completed a $1 million private placement offering of its convertible Series E Preferred Stock to accredited investors. The transaction closed on March 21, 2025, and was conducted without the involvement of a placement agent, broker, or […]

In January we saw a proposed rule change for NASDAQ listing standards.  After a short delay in approval these changes are now official and will be in place for all new listings post April 11th of this year. What is the new NASDAQ Listing Rule? The rule now changes the minimum market value of unrestricted […]

We are pleased to announce that Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, CYCCP) has completed a successful share purchase and change in control, marking a significant milestone for the company as it transitions leadership and charts a new path forward. ARC Group assisted in facilitating the sale of 70% of Cyclacel’s issued and outstanding shares to […]

ARC Group, a leading global investment banking and management consultancy firm, successfully hosted the Capital Markets & M&A Forum Shanghai 2025 at the Shangri-La Hotel, marking its 10th anniversary and reaffirming its commitment to fostering global investment and financial innovation. The milestone event brought together industry leaders, institutional investors, and corporate executives to discuss the […]

ARC Group, a leading global investment banking and management consulting firm, is proud to celebrate its 10th anniversary, marking a decade of strategic expansion, market expertise, and a steadfast commitment to client success. Since its founding in 2015, ARC Group has established itself as a premier mid-market financial advisory firm, bridging capital markets across Asia, […]

D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, today announced it has secured significant strategic investments from an institutional investor and ARC Group, a leading global investment bank and management consultancy firm. These partnerships position D. Boral Capital for accelerated growth and innovation in the coming years. “These strategic […]

ARC Group Limited, a leading global investment bank, is pleased to announce the signing of an engagement agreement with METAVISIO – THOMSON Computing (FR00140066X4; Ticker: ALTHO). This collaboration, unveiled during CES 2025, positions METAVISIO for a prospective listing on Nasdaq or the New York Stock Exchange (NYSE) in the United States, with a minimum indicative […]

What is the new Rule? NASDAQ has recently proposed a new change on how issuers list on their exchange.  This rule has not yet been approved and is currently open for comments at the SEC until January 21st.  The proposal is a to change rule 5405 and 5505 on the minimum market value of unrestricted […]

ARC Group is proud to announce its sponsorship of Team ARC in their upcoming participation at the 16th China Cup International Regatta 2024, Asia’s largest and internationally renowned sailing event. The competition will take place from October 31 to November 4, 2024, in Greater Bay, Shenzhen. This sponsorship reflects ARC Group’s commitment to fostering excellence […]

ARC Group is pleased to announce its role as the financial advisor to Gelteq Limited (“Gelteq”), a pioneering biotechnology firm, in its initial public (IPO) offering on Nasdaq. Gelteq has priced its IPO of 1,300,000 ordinary shares at US$4.00 per share, yielding gross proceeds of US $5.2 million. Trading commenced yesterday on Nasdaq on October […]

ARC Group Limited is proud to announce the successful completion of a strategic divestment by Fresenius Medical Care AG (ETR: FME). The transaction involved the sale of Fresenius Medical Care’s equity interest in six hospital centers in China, owned by Jiangsu Fresenius Medical Care Hospital Management Services Co., Ltd., to Jiangxi Dakang Medical Management Co., […]

We are proud to announce that ARC Group has been honored with the prestigious 2024 Frost & Sullivan Company of the Year Award for the Asian mid-market investment advisory services industry. This recognition underscores ARC Group’s continued commitment to innovation, growth, and delivering exceptional value to its clients across Asia-Pacific and beyond. Presented by Frost […]

ARC Group marked a significant milestone last week with the opening event of its new Vietnam office, located in the vibrant Binh Thanh District of Ho Chi Minh City. Situated on the 28th floor of Pearl Plaza, this new space not only represents ARC Group’s expanding presence in the region but also reinforces the company’s […]

ARC Group, a leading global advisory firm, has been prominently featured in the September-October 2024 edition of The Smart Investor. Known for its expertise in Special Purpose Acquisition Companies (SPACs), ARC Group has successfully facilitated over 50 SPAC listings on major U.S. stock exchanges, including the New York Stock Exchange and NASDAQ, cementing its position […]

Since our establishment in 2016, ARC Group has cemented its position as a leading financial services provider, renowned for its comprehensive offerings in capital markets, M&A, and financial advisory. Recognized for excellence across global markets, ARC Group has received numerous accolades, including the “Best Mid-Market Boutique Investment Bank” award from International Investors magazine in 2020, […]

On September 6, 2024, ARC Group formalized a strategic Memorandum of Understanding (MoU) with the Vietnam Trade Office in Sweden, marking a significant milestone in enhancing economic cooperation. The signing took place as part of a broader celebration, which also commemorated Vietnam’s National Day on September 2 and 55 years of diplomatic relations between Vietnam […]

We would like to extend our heartfelt thanks to everyone who joined us in celebrating the launch of our new Shanghai office at the prestigious Jing’an Kerry Centre. Your presence made this milestone even more memorable, and we are grateful to have shared this special occasion with our clients, partners, and colleagues. Our new office, […]

We are pleased to announce the successful agreement of a definitive business combination between Evergreen Corporation (NASDAQ: EVGR) and Forekast Limited, a leading technology managed services provider specializing in augmented intelligence. This strategic merger, expected to close by the end of 2025, will form a combined entity, Forekast Group (“PubCo”), accelerating Forekast’s growth trajectory and […]